查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1983831

穿戴式驅蟲劑市場：2026-2032 年全球市場預測（按產品類型、活性成分、包裝、最終用戶、分銷管道和銷售形式分類）。

Body Worn Insect Repellents Market by Product Type, Active Ingredient, Packaging Type, End User, Distribution Channel, Sales Mode - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，穿戴式驅蚊劑市場價值將達到 6.3124 億美元，到 2026 年將成長至 6.9321 億美元，到 2032 年將達到 11.8372 億美元，複合年成長率為 9.39%。

主要市場統計數據
基準年 2025 6.3124億美元
預計年份：2026年 6.9321億美元
預測年份 2032 1,183,720,000 美元
複合年成長率 (%) 9.39%

本文從消費者、通路和監管重點的角度，簡要總結了當前重塑穿戴式式驅蟲劑的趨勢。

目前，穿戴式驅蚊產品市場呈現公共衛生優先事項、消費者行為變化以及活性成分和輸送系統技術快速創新三者交匯的特徵。人們對蟲媒疾病的認知不斷提高，加上戶外休閒的增加和移動生活方式的興起，正在改變消費者對防護技術的評價。這些趨勢迫使製造商重新思考其配方、包裝的便利性和傳播策略，同時還要滿足不斷變化的監管要求，這些要求既重視功效也重視安全性。

消費者優先事項的演變、銷售管道的演變以及監管重點的加強，正在對穿戴式驅蚊劑的競爭優勢進行動態重組。

重大變革重塑了人體驅蚊產品的競爭格局與發展機會。首先，消費者的期望日趨成熟。如今，除了防護功能外，消費者還要求產品外觀時尚、氣味低，且成分說明清晰明了，以滿足各個年齡層的日常使用需求。這促使研發投入轉向傳統化學成分的替代品和微配方技術，以在保持有效性的同時提升舒適度。

2025 年的關稅調整過程製造商重新思考其生產地點、定價策略和供應彈性，因為他們已經重新調整了採購重點。

2025年關稅的實施和貿易政策的調整，為依賴跨境供應鏈獲取活性成分、包裝材料和成品的企業帶來了實際的挑戰。以往以最低交付成本為目標的製造商，如今面臨短期成本上升和長期供應穩定性之間的權衡。因此，採購團隊正在重新評估供應商組合，加快對替代供應商的認證，並簽訂長期合約以確保供應的連續性。

解讀橫斷面細分趨勢，以確定影響購買行為的關鍵配方、包裝和管道策略。

對市場區隔的多方面理解有助於明確消費者偏好、通路機制和配方科學如何交匯，從而創造差異化價值。分析線上和線下銷售模式可以發現購買行為的差異。實體店仍然是試用裝、衝動消費和老年人的主要接觸點，而線上通路則迎合了更年輕、更熟悉數位科技的消費者，他們更重視訂閱、重複購買、用戶評價和D2C（直接面對消費者）服務。從終端使用者的觀點來看，成人和兒童產品需要不同的配方、安全標籤和包裝。兒童產品優先考慮易用性、低致敏性和讓家長放心，而成人產品則需要在功效和生活方式導向型功能（例如低香精和防汗）之間取得平衡。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和消費者期望正在塑造產品差異化、法規和分銷策略。

區域趨勢差異顯著，因此在產品陣容、法規遵循和市場准入方面需要採取本地化策略。在美洲，消費者偏好便利的產品形式，以支持戶外休閒和旅行。該地區的零售生態系統由大型超級市場和強大的藥局網路組成，這些藥局優先銷售知名品牌和可靠的功效聲明。此外，該地區對集驅蚊、防曬油和護膚功效於一體的多功能產品需求旺盛，這為產品捆綁銷售和共同行銷創造了機會。

獨特的企業策略與夥伴關係模式，定義了從成熟企業到創新者等各類公司在穿戴式驅蚊劑領域的競爭定位。

這類公司的競爭行為體現了三種平行的策略策略：規模優勢驅動的成熟企業、專注於創新的專業公司以及嘗試D2C（直接面對消費者）模式的新興挑戰者。大型消費品公司利用其廣泛的分銷網路、已建立的信任和業務關係，保持與主要零售商的議價能力，並在商店上佔據顯著位置。它們的投資往往側重於配方永續性、品牌信譽和遵守全球法規。

為產品、供應鏈和銷售領導者提供可操作的策略重點，以加速產品推廣、管理風險並保持競爭優勢。

產業領導者應推動一系列整合舉措，協調產品開發、通路策略和法規遵從，以掌握短期機會並建立長期韌性。優先開發能夠提升化妝品接受度和安全性的配方，同時檢驗在典型使用條件下的有效性。投資進行皮膚科試驗和真實世界使用試驗，可以增強產品功效的宣傳力度，並減少消費者的猶豫。同時，開發兼顧便利性和永續性的包裝創新，盡可能採用可重複填充和輕量化包裝，從而降低物流成本和環境影響。

採用嚴謹透明的研究途徑，結合一手訪談、零售審計、監管審查和技術文獻，以檢驗見解和建議。

本研究整合了一手和二手數據，對穿戴式驅蚊劑市場進行了穩健且可重複的分析。一手資料包括對配方研發人員、採購經理、零售品類經理和公共衛生專家的結構化訪談，並輔以對生產和履約設施的實地考察，以檢驗物流方面的假設。二手資訊來源包括同行評審的毒理學和昆蟲學文獻、監管文件、專利申請以及公開的公司披露資訊，以確保技術聲明的評估基於最新的科學共識。

結論是，關鍵要素之間的相互作用——技術可靠性、健全的採購系統和以客戶為中心的產品開發——將決定未來的贏家。

穿戴式驅蚊產品市場正處於策略轉折點，消費者期望、成分創新和供應鏈現狀在此交匯，重塑競爭格局。能夠將科學可信的產品聲明、卓越的易用性和流暢的購買體驗相結合的企業，將贏得市場。同樣重要的是，企業要能預見政策變化，並制定籌資策略，在保障消費者價值的同時，降低成本和物流中斷所帶來的風險。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：穿戴式驅蚊劑市場：依產品類型分類

  • 洗劑
  • 修補
  • 噴
  • 濕紙巾
  • 腕帶

第9章：依活性成分分類的穿戴式驅蟲劑市場。

  • DEET
  • IR3535
  • 檸檬尤加利油
  • 派卡瑞丁

第10章：穿戴式驅蚊劑市場：依包裝類型分類

  • 氣霧劑
  • 泵式噴霧
  • 滾珠式
  • 擦拭巾包

第11章：穿戴式驅蟲劑市場：以最終用戶分類

  • 成人版
  • 孩子

第12章：穿戴式驅蚊劑市場：依分銷管道分類

  • 便利商店
  • 線上零售
  • 藥局
  • 專賣店
  • 超級市場和大賣場

第13章：依銷售方式分類的穿戴式驅蚊劑市場

  • 離線
  • 線上

第14章：穿戴式驅蚊劑市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：穿戴式驅蚊劑市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：穿戴式驅蚊劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國穿戴式驅蚊劑市場

第18章：中國穿戴式驅蚊劑市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Babyhug
  • Bushman Repellent
  • Coghlan's Ltd.
  • Dabur International Limited
  • Enesis Group
  • ExOfficio LLC,
  • Forest Essentials
  • Heritancy Manufacturers
  • Himalaya Wellness Company
  • Honasa Consumer Limited
  • Incognito
  • Jungle Formula by Perrigo Company plc
  • MACROVITA.pl
  • Merck KGaA
  • Mirah Belle Naturals & Apothecary Pvt. Ltd.
  • Mother Sparsh Baby Care Private Limited
  • MyVitaly srl
  • Nature's Botanical
  • Newell Brands Inc.
  • Oleum Cottage
  • SC Johnson & Son, Inc.
  • Sawyer
  • Shantou SEZ Baojie Industrial Co., Ltd
  • Swadesh International
Product Code: MRR-F6513A06BE86

The Body Worn Insect Repellents Market was valued at USD 631.24 million in 2025 and is projected to grow to USD 693.21 million in 2026, with a CAGR of 9.39%, reaching USD 1,183.72 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 631.24 million
Estimated Year [2026] USD 693.21 million
Forecast Year [2032] USD 1,183.72 million
CAGR (%) 9.39%

A concise framing of the contemporary forces reshaping body-worn insect repellents across consumers, channels, and regulatory priorities

The landscape of body-worn insect repellents now intersects public health priorities, consumer behavior shifts, and rapid innovation in active ingredients and delivery systems. Rising awareness of vector-borne illnesses, combined with expanded outdoor recreation and the normalization of mobile lifestyles, has changed how consumers evaluate protection technologies. These dynamics are driving manufacturers to rethink formulations, packaging convenience, and communication strategies while also navigating evolving regulatory expectations that prioritize both efficacy and safety.

Today's product conversations are less about single attributes and more about integrated value propositions that span duration of protection, skin feel, scent profile, and environmental considerations. In parallel, retail strategies must reconcile traditional brick-and-mortar strengths with accelerating digital discovery, curation, and fulfillment. The cumulative effect is a richer competitive environment where nimble brands, ingredient pioneers, and channel specialists can capture new demand by aligning technical performance with modern consumer preferences.

This introduction frames the remainder of the executive summary by outlining the drivers, constraints, and stakeholder priorities that shape commercial decisions across product development, supply chain design, and go-to-market execution. The intent is to provide leaders with pragmatic context that supports immediate strategic choices and longer-term portfolio planning.

Emerging consumer priorities, channel evolution, and regulatory emphasis creating a dynamic reordering of competitive advantage in body-worn repellents

Significant transformative shifts have reconfigured competitive dynamics and opportunity spaces for body-worn insect repellents. First, consumer expectations have matured: protection must now coexist with cosmetic elegance, low-odor formulations, and clear ingredient narratives that support daily use across age groups. This has catalyzed R&D investments into alternatives to legacy chemistries and into microformulation techniques that preserve efficacy while enhancing wearability.

Second, distribution and purchase pathways are evolving rapidly. Brick-and-mortar retail remains essential for trial and immediate need, whereas online channels dominate discovery, subscription models, and replenishment. This duality compels brands to harmonize experiential merchandising with data-driven digital journeys, leveraging content, reviews, and targeted promotions to reduce friction from interest to adoption.

Third, regulatory and policy developments have heightened scrutiny on active ingredients, labeling clarity, and environmental impact. As regulators emphasize transparent risk communication and robust safety data, manufacturers must invest earlier in regulatory science and post-market surveillance. Lastly, climate and epidemiological trends have made vector-control strategies more salient, increasing partnership opportunities between private firms, public health agencies, and community programs. Together, these shifts demand integrated strategies that align technical innovation, channel orchestration, and regulatory engagement.

How 2025 tariff adjustments reshaped sourcing priorities and compelled manufacturers to rethink production footprints, pricing tactics, and supply resilience

The imposition of tariffs and trade policy adjustments in 2025 has introduced tangible complexity for players relying on cross-border supply chains for active ingredients, packaging substrates, and finished goods. Manufacturers that previously optimized for lowest landed cost now face the trade-off between near-term cost inflation and longer-term supply resilience. As a result, procurement teams are reassessing supplier portfolios, accelerating qualification of alternative vendors, and engaging in longer-term contracting to preserve continuity of supply.

Tariff effects have prompted a re-evaluation of production footprints. Some firms are exploring regional manufacturing or toll-fill partnerships to localize critical production steps and reduce exposure to import levies. Others are absorbing costs selectively to preserve shelf pricing in sensitive channels, while selectively passing through price increases where premium positioning allows. The net outcome has been a greater emphasis on supply chain visibility, scenario planning, and inventory strategy to mitigate volatility.

Concurrently, tariff-driven cost pressures have accelerated interest in packaging optimization and formulation efficiency that reduce weight and volume without compromising performance. Firms are also investing in supplier collaboration to identify tariff classifications, origin certifications, and duty mitigation strategies. For buyers and strategists, the 2025 tariff environment underscores the importance of adaptive sourcing, commercial flexibility, and close coordination between procurement, R&D, and commercial teams to sustain product availability and margin integrity.

Interpreting cross-cutting segmentation dynamics to pinpoint high-impact formulation, packaging, and channel strategies that influence purchase behavior

A nuanced understanding of segmentation helps clarify where consumer preferences, channel mechanics, and formulation science intersect to create differentiated value. Examining how sales mode divides between offline and online reveals divergent purchase behaviors: brick-and-mortar remains a primary touchpoint for trial, impulse purchase, and older demographics, while online channels facilitate subscription, repeat purchase, and younger, digitally native consumers who rely on reviews and direct-to-consumer offers. Looking through the lens of end user, adult and child segments demand distinct formulation, safety labeling, and packaging cues; child-focused products prioritize ease of application, hypoallergenic claims, and parental reassurance, whereas adult offerings balance efficacy with lifestyle-oriented attributes such as low scent or sweat-resistance.

Active ingredient segmentation-Deet, IR3535, oil of lemon eucalyptus, and picaridin-highlights technical trade-offs among broad-spectrum performance, dermatological acceptability, and consumer perceptions about natural versus synthetic chemistries. Each ingredient class carries different regulatory touchpoints and communication strategies. Packaging type-ranging from aerosols and pump sprays to roll-ons and wipe packs-drives usage occasions and distribution suitability, with compact wipes and roll-ons favored for travel and convenience while pumps and aerosols suit longer-duration outdoor scenarios. Product type diversity, including lotions, patches, sprays, wipes, and wristbands, creates differentiated propositions for continuous wear, spot application, and family use. Finally, distribution channel segmentation across convenience stores, online retail, pharmacy drug stores, specialty stores, and supermarket hypermarkets demands tailored assortment, pricing, and promotional tactics to align with shopper missions and in-store discovery behaviors.

These intersecting segmentation dimensions reveal where performance innovation, packaging design, and channel investment will most effectively convert preference into repeat purchase. Understanding how each axis influences the others enables manufacturers to prioritize SKUs, communication strategies, and retail partnerships for the greatest commercial impact.

Region-specific dynamics and consumer expectations shaping differentiated product, regulatory, and distribution strategies across Americas, EMEA, and Asia-Pacific

Regional dynamics vary widely and require tailored approaches to product assortment, regulatory compliance, and go-to-market execution. In the Americas, consumer preferences skew toward convenience formats that support outdoor leisure and travel, and retail ecosystems combine large-format grocery with robust pharmacy networks that favor recognizable brand names and trusted efficacy claims. This region also exhibits strong demand for multifunctional products that integrate insect protection with sun care or skincare benefits, prompting product bundling and co-marketing opportunities.

In Europe, Middle East & Africa, regulatory frameworks and public health priorities create a complex operating environment where ingredient approvals and labeling conventions differ across jurisdictions. Consumers in parts of Europe display heightened interest in sustainability credentials and natural-sourced ingredients, while in parts of Africa and the Middle East, priorities often center on proven protection against a range of vectors under challenging environmental conditions. These contrasts require adaptive regulatory strategies and localized communication that emphasize credible safety and efficacy substantiation.

The Asia-Pacific region presents a combination of high-volume, price-sensitive channels alongside rapidly expanding urban middle-class cohorts that seek premiumized, technologically advanced repellents. E-commerce and mobile commerce growth in key markets accentuates digital-first commercial models, while regional manufacturing hubs offer opportunities for cost-efficient production and faster time-to-market. Across all regions, cultural attitudes toward scent, texture, and application format materially influence product acceptance, making local consumer insight essential for successful regional rollouts.

Distinct corporate strategies and partnership models that determine competitive positioning from incumbents to innovators in body-worn repellent categories

Competitive behavior among companies in this category reflects three parallel strategic approaches: scale-driven incumbent advantage, focused innovation by specialized firms, and emerging challengers experimenting with direct-to-consumer models. Large consumer goods companies leverage broad distribution networks, established trust, and trade relationships to maintain prominent shelf presence and negotiation power with major retailers. Their investments tend to emphasize formulation longevity, brand reassurance, and global regulatory compliance.

Specialized manufacturers and ingredient innovators concentrate on technical differentiation-novel delivery systems, microencapsulation, and plant-derived actives-often partnering with contract manufacturers to accelerate commercialization. These firms drive category discourse around efficacy metrics and dermatological performance, and they frequently collaborate with academic or public health institutions to validate claims. Newer challengers are testing subscription models, experiential marketing, and influencer-led education to shorten adoption cycles and build direct consumer relationships; these approaches create valuable first-party data streams for rapid iteration.

Across company types, successful strategies increasingly combine rigorous safety substantiation with clear consumer communication, supply chain transparency, and selective channel investments. Partnerships that align technical expertise with distribution scale are common, and licensing or co-branding arrangements help accelerate portfolio breadth without duplicative capital outlay. Finally, companies that proactively engage with regulatory authorities and public health stakeholders tend to navigate approvals and market entry more smoothly while earning institutional credibility.

Actionable strategic priorities for product, supply chain, and commercial leaders to accelerate adoption, manage risk, and sustain competitive differentiation

Industry leaders should pursue an integrated set of actions that align product development, channel strategy, and regulatory engagement to capture near-term opportunities and build long-term resilience. Prioritize formulation workstreams that enhance cosmetic acceptability and safety while validating efficacy across representative use conditions; investing in dermatological testing and real-world wear studies will strengthen claims and reduce consumer hesitation. Simultaneously, deploy packaging innovation that balances convenience with sustainability, using refillable or lightweight formats where feasible to reduce logistics cost and environmental footprint.

On the commercial front, harmonize offline trial pathways with digital-first replenishment experiences; enable seamless omnichannel discovery through consistent product messaging and subscription options that encourage repeat purchase. Strengthen procurement resilience by diversifying suppliers for key actives and packaging components, and by qualifying regional contract manufacturers to mitigate tariff exposure and shorten lead times. Engage proactively with regulatory agencies and public health bodies to co-develop acceptable risk communication frameworks and to expedite approvals where new ingredient classes or delivery systems are introduced.

Finally, scale data capabilities to capture post-purchase performance signals and consumer feedback. Deploy structured post-market surveillance and integrate learnings into rapid reformulation cycles. These combined measures will improve customer trust, support premium positioning where warranted, and protect margins in volatile trade environments.

A rigorous, transparent research approach combining primary interviews, retail audits, regulatory review, and technical literature to validate insights and recommendations

This research synthesizes primary and secondary evidence to deliver a robust, reproducible analysis of the body-worn insect repellent space. Primary inputs include structured interviews with formulators, procurement leads, retail category managers, and public health experts, complemented by targeted site visits to manufacturing and fulfillment facilities to validate logistical assumptions. Secondary inputs encompass peer-reviewed toxicology and entomology literature, regulatory dossiers, patent filings, and publicly available corporate disclosures to ensure technical claims are evaluated against the latest scientific consensus.

Data triangulation procedures were applied to reconcile differences between self-reported commercial behavior and observed retail activity. Retail audits and e-commerce assortment mapping provided real-world visibility into pricing, packaging, and promotional tactics across channels. Ingredient performance assessments referenced independent laboratory tests and standardized insect challenge studies where available, and regulatory risk analysis was informed by jurisdictional guidance and precedent decisions. All insights were subject to expert validation through advisory panels and cross-disciplinary review to ensure analytical rigor, transparency of assumptions, and practical relevance for commercial decision-makers.

Concluding synthesis on the critical interplay of technical credibility, resilient sourcing, and customer-centric commercialization shaping future winners

The body-worn insect repellent sector stands at a strategic inflection point where consumer expectations, ingredient innovation, and supply chain realities converge to reshape competitive patterns. Companies that succeed will be those that pair scientifically credible product claims with superior sensory profiles and frictionless purchase experiences. Equally important is the ability to anticipate policy shifts and to build sourcing strategies that reduce exposure to cost and logistical disruption while preserving consumer value propositions.

Looking forward, the most promising pathways involve cross-functional collaboration between R&D, regulatory affairs, procurement, and commercial teams to create synchronized product launches and resilient distribution plans. Brands that invest in transparent communication, validated safety data, and amenity-driven formulations are positioned to win trust and loyalty across diverse demographic and regional contexts. In sum, the combination of technical rigor, adaptive supply chain design, and customer-centric commercialization will determine which organizations capture sustainable advantage in this evolving category.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Body Worn Insect Repellents Market, by Product Type

  • 8.1. Lotion
  • 8.2. Patch
  • 8.3. Spray
  • 8.4. Wipe
  • 8.5. Wristband

9. Body Worn Insect Repellents Market, by Active Ingredient

  • 9.1. Deet
  • 9.2. Ir3535
  • 9.3. Oil Of Lemon Eucalyptus
  • 9.4. Picaridin

10. Body Worn Insect Repellents Market, by Packaging Type

  • 10.1. Aerosol
  • 10.2. Pump Spray
  • 10.3. Roll On
  • 10.4. Wipe Pack

11. Body Worn Insect Repellents Market, by End User

  • 11.1. Adult
  • 11.2. Child

12. Body Worn Insect Repellents Market, by Distribution Channel

  • 12.1. Convenience Store
  • 12.2. Online Retail
  • 12.3. Pharmacy Drug Store
  • 12.4. Specialty Store
  • 12.5. Supermarket Hypermarket

13. Body Worn Insect Repellents Market, by Sales Mode

  • 13.1. Offline
  • 13.2. Online

14. Body Worn Insect Repellents Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Body Worn Insect Repellents Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Body Worn Insect Repellents Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Body Worn Insect Repellents Market

18. China Body Worn Insect Repellents Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. 3M Company
  • 19.6. Babyhug
  • 19.7. Bushman Repellent
  • 19.8. Coghlan's Ltd.
  • 19.9. Dabur International Limited
  • 19.10. Enesis Group
  • 19.11. ExOfficio LLC,
  • 19.12. Forest Essentials
  • 19.13. Heritancy Manufacturers
  • 19.14. Himalaya Wellness Company
  • 19.15. Honasa Consumer Limited
  • 19.16. Incognito
  • 19.17. Jungle Formula by Perrigo Company plc
  • 19.18. MACROVITA.pl
  • 19.19. Merck KGaA
  • 19.20. Mirah Belle Naturals & Apothecary Pvt. Ltd.
  • 19.21. Mother Sparsh Baby Care Private Limited
  • 19.22. MyVitaly s.r.l.
  • 19.23. Nature's Botanical
  • 19.24. Newell Brands Inc.
  • 19.25. Oleum Cottage
  • 19.26. S. C. Johnson & Son, Inc.
  • 19.27. Sawyer
  • 19.28. Shantou S.E.Z Baojie Industrial Co., Ltd
  • 19.29. Swadesh International

LIST OF FIGURES

  • FIGURE 1. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BODY WORN INSECT REPELLENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BODY WORN INSECT REPELLENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BODY WORN INSECT REPELLENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BODY WORN INSECT REPELLENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY LOTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY LOTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY LOTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY WIPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY WIPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY WIPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY WRISTBAND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY WRISTBAND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY WRISTBAND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY DEET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY DEET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY DEET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY IR3535, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY IR3535, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY IR3535, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY OIL OF LEMON EUCALYPTUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY OIL OF LEMON EUCALYPTUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY OIL OF LEMON EUCALYPTUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PICARIDIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PICARIDIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PICARIDIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY AEROSOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY AEROSOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY AEROSOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PUMP SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PUMP SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PUMP SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ROLL ON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ROLL ON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ROLL ON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY WIPE PACK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY WIPE PACK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY WIPE PACK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY CHILD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY CHILD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY CHILD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY CONVENIENCE STORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY CONVENIENCE STORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY CONVENIENCE STORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PHARMACY DRUG STORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PHARMACY DRUG STORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY PHARMACY DRUG STORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY SPECIALTY STORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY SPECIALTY STORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY SPECIALTY STORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY SUPERMARKET HYPERMARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY SUPERMARKET HYPERMARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY SUPERMARKET HYPERMARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS BODY WORN INSECT REPELLENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GCC BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 142. GCC BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. GCC BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. GCC BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. GCC BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 163. G7 BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. G7 BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. G7 BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. G7 BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 167. NATO BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. NATO BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 170. NATO BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NATO BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. NATO BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL BODY WORN INSECT REPELLENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES BODY WORN INSECT REPELLENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA BODY WORN INSECT REPELLENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA BODY WORN INSECT REPELLENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA BODY WORN INSECT REPELLENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA BODY WORN INSECT REPELLENTS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA BODY WORN INSECT REPELLENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA BODY WORN INSECT REPELLENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA BODY WORN INSECT REPELLENTS MARKET SIZE, BY SALES MODE, 2018-2032 (USD MILLION)